^
BIOMARKER:

ER Y537S

i
Other names: ESR1, Era, ESR, NR3A1, ER, ER beta
Entrez ID:
ER Y537S
HER2 Negative Breast Cancer
H3B-6545
Sensitive: C2 – Inclusion Criteria
ER Y537S
HER2 Negative Breast Cancer
SAR439859
Sensitive: C3 – Early Trials
ER Y537S
Estrogen Receptor Positive Breast Cancer
fulvestrant
Sensitive: C3 – Early Trials
ER Y537S
HER2 Negative Breast Cancer
palbociclib + PF-05212384
Sensitive: C3 – Early Trials
ER Y537S
Breast Cancer
tamoxifen
Sensitive: C4 – Case Studies
ER Y537S
Estrogen Receptor Positive Breast Cancer
SAR439859
Sensitive: D – Preclinical
ER Y537S
Estrogen Receptor Positive Breast Cancer
OP-1250
Sensitive: D – Preclinical
ER Y537S
Breast Cancer
OP-1250
Sensitive: D – Preclinical
ER Y537S
Breast Cancer
ZN-c5
Sensitive: D – Preclinical
ER Y537S
Estrogen Receptor Positive Breast Cancer
lasofoxifene
Sensitive: D – Preclinical
ER Y537S
Breast Cancer
LY3484356
Sensitive: D – Preclinical
ER Y537S
Estrogen Receptor Positive Breast Cancer
GDC-9545
Sensitive: D – Preclinical
ER Y537S
Estrogen Receptor Positive Breast Cancer
CDK4 inhibitor + GDC-9545
Sensitive: D – Preclinical
ER Y537S
Estrogen Receptor Positive Breast Cancer
CDK6 inhibitor + GDC-9545
Sensitive: D – Preclinical